. In protocol 1, E.sEST underestimated EesTRUE by about 16% (E.SEST, 6 .49+1.55 mm Hg/mL; E STRUE, 7 .48±1.29 mm Hg/mL; P<.02). In protocol 2, BesEST overestimated EeSTRUE by about 37% (EesEST, 9-99+3-97 mm Hg/mL; EesTRUE, 6 .43±3.88 mm Hg/mL; P<.007).
Conclusions In conscious, autonomically intact dogs, the use of stepwise, steady-state afterload variations to obtain ESP-ESV data points to construct the ESPVR incorrectly estimates Ees. In the case of afterload reduction, EesTRUE is underestimated an average of 16 .3%, and in the case of afterload increase, EeSTRUE is overestimated an average of 37 .1%. These errors should be taken into account when interpreting clinical studies using this methodology. (Circulation. 1994; 90:1431 -1440 Key Words * elastance * afterload * pressure-volume relation * contractility E nd-systolic elastance (Ees), the slope parameter of the end-systolic pressure (ESP)-volume (ESV) relation (ESPVR) has been proposed as an index of left ventricular (LV) contractility, due to its sensitivity to changes in inotropic state and to its relative insensitivity to changes in LV loading conditions.1-3
To construct the ESPVR, a series of ESP-ESV data points over a range of values of ESP and ESV are needed. In experimental animals, this is usually achieved through an abrupt and short-lasting preload reduction generated by inferior vena caval occlusion (IVCO).4-7 This method, which has also been used in humans,8-'4 has two important properties: first, the decrease in preload occurs on a beat-to-beat basis, thus permitting the ESPVR to be constructed using a large number of ESP-ESV data points; and second, its dura-tion is shorter than the time required by the baroreflex to induce an increase in contractility, thus preventing inotropic changes from occurring during the maneuver.
To By applying the same protocol but using angiotensin II instead of sodium nitroprusside, we also investigated whether the ESPVR constructed on the basis of the opposite loading change, ie, stepwise afterload increases, yielded reliable estimates of true end-systolic elastance.
Methods
The surgical preparation and experiments (as well as the transportation, housing, and care of the animals) were conducted according to the guiding principles of the American Physiological Society.
Surgical Preparation
Ten adult mongrel dogs of either sex, weighing 19.6±0.9 kg (mean±SD), were operated on. Anesthesia was induced using intravenous thiopental sodium (25 mg/kg) and maintained with 2% enflurane. Instrumentation has been described in detail elsewhere.33 Briefly, three pairs of ultrasonic microcrystals were positioned to measure LV internal apex-base, septum-free wall, and anteroposterior diameters; a high-fidelity pressure microtransducer (Konigsberg P7, Konigsberg Instruments) together with a fluid-filled catheter for its calibration was inserted in the LV cavity; a pneumatic cuff occluder was positioned around the inferior vena cava; a fluid-filled catheter for drug infusion was introduced into the right atrium, and pacing wires were sutured to the left atrial appendage. All cables and catheters were tunnelled subcutaneously to emerge at the interscapular space, and the thoracotomy was repaired without closing the pericardium.
Experimental Protocol
Experiments were performed 3 to 4 weeks after surgery, with the conscious, unsedated, autonomically intact dog lying on its right side. The three pairs of ultrasonic microcrystals were connected to a sonomicrometer (Triton Technology), and the ventricular fluid-filled catheter was connected to a pressure transducer (Statham P23 Db) that had been calibrated using a mercury column, with the zero reference point set at the level of the spine. The signal generated by the high-fidelity pressure microtransducer was then adjusted to match the signal provided by the fluid-filled catheter. The three diameter signals and the pressure signal were digitized on-line every 5 milliseconds over 15 seconds with an analogdigital converter (Data Translation 2801-A) coupled to a personal computer, and the calibrated pressure-volume (P-V) loops were displayed.
Protocol 1
In 7 dogs, the protocol included three experimental conditions: control, first level of afterload reduction, and second level of afterload reduction. In two dogs exhibiting physiological sinus arrhythmia during the control condition, the heart was paced (Medtronics 5325) at a heart rate (HR) that was 10% above spontaneous HR. These dogs did not exhibit arrhythmia under changed afterload conditions. After stabilization, two sets of recordings were made: first, a series of at least 10 steady-state beats for the measurement of hemodynamic parameters, and second, immediately afterward, all beats occurring during an acute, short-lasting (maximum, 12 seconds) IVCO, for the construction of the ESPVR. The nitroprusside infusion was started at a rate of 1.7 ig . kg' -min`and then adjusted to cause a decrease in ESP of at least 10% with regard to control, which was achieved at a rate of 2.2±0.6 jig -kg-' 1 min`. After recording the signals during steady-state conditions and IVCO, we augmented the infusion rate to produce a further decrease in ESP of at least 10% with regard to the first level of afterload reduction. This was achieved with a dose of 5.1±1.9 ,ug . kg-l . minml. Then, the final recordings under steady-state conditions and during IVCO were made.
Protocol 2
In 3 dogs from protocol 1 and in three additional dogs, a second protocol consisting of two levels of angiotensin IIinduced afterload increase was carried out on a different day. After control recordings of the steady state and the IVCO, angiotensin II was infused (4.3± 1.0 ,gg kg`. min-1) to increase ESP at least 10% above control values. After new recordings of the steady state and the IVCO, angiotensin II infusion was augmented (9.9±3.3 ,gg kg-. min-') until ESP was at least 10% higher than during the previous level of afterload increase. The final recordings of the steady state and of the IVCO were made, and the dog was killed using an overdose of thiopental sodium followed by a lethal injection of potassium chloride. Correct microcrystal positioning was verified at necropsy.
Data Analysis
The information recorded consisted of steady-state beats and those from IVCO under each experimental condition. The beats from IVCO were the first to be analyzed to calculate the parameters of the ESPVR according to the iterative method described by Kono et al.34 The resulting volume axis intercept (V0) value was then used to identify the end-systolic point in each of the steady-state beats as the maximum ratio of LVP to (LVV-VO). In all cases, LV volume (LVV) (in mL) was calculated as:
where ABD, APD, and SFWD are the apex-base, anteroposterior, and septum-free wall internal diameters, respectively.
The digitally calculated first derivative of LVP (dP/dt) was used as the reference signal to define end diastole (at the onset of its rapid upstroke), onset ejection (at its peak positive value), and end ejection (at its peak negative value).
For each experimental step, the beats recorded during steady-state conditions were averaged for the calculation of HR, LV ESP, peak-systolic (PSP), and end-diastolic (EDP) pressures; LV end-diastolic (EDV), onset ejection (OEV), end-ejection (EEV), and end-systolic (ESV) volumes; anteroposterior diameter at onset ejection (OE) and at end ejection (EE); and the maximum value of dP/dt (dP/dtm,,). Stroke volume (SV) (in mL), ejection fraction (EF) (in percent), cardiac output (CO) (in L/min), and mean velocity of circumferential fiber shortening (Vcf) (in s-1) were 
Statistical Analysis
Analysis of variance for repeated measures was used to process the results corresponding to the three experimental conditions of the afterload decrease protocol (protocol 1) and the three experimental conditions of the afterload increase protocol (protocol 2). In each protocol, when the F value showed that significant differences were present, the Tukey B test37 was used to compare the control condition with the first and second levels of afterload modification. In each protocol, paired t tests were used to compare the estimated Be, with the corresponding true control E,,. In all cases, a value of P<.05 was considered to indicate statistically significant differences. All results are expressed as mean+SD.
Results Fig 2 shows the P-V loops obtained during IVCO under all experimental conditions in a dog displaying small changes in the position of the ESPVR. Fig 3, on the other hand, is an example of a dog displaying larger changes in response to loading variations. Protocol 1 Table 1 shows the values for the hemodynamic variables and indexes of contractility as well as the correlation coefficients and number of data points of the ESPVRs. Both rates of nitroprusside infusion induced significant decreases in ESP, EDP, ESV, and EDV. A significant HR increase was observed only at the second level of afterload reduction, which also resulted in a significant fall in EF, whereas dP/dtma,,, Vcf, and Mw remained unchanged. On the other hand, dE/dtmax increased significantly under both rates of nitroprusside infusion. Note that the dE/dtmax value reported is based on six observations, since in one dog dP/dtm. showed a paradoxical progressive increase during the occlusion, yielding a negative dE/dtma,x value. Ees increased with nitroprusside infusion, but only at the higher infusion rate did the increase achieve statistical significance. 14±5 17±6 13±4 NPS-1 indicates lower rate of sodium nitroprusside infusion; NPS-2, higher rate of sodium nitroprusside infusion; HR, heart rate; bpm, beats per minute; LVESP, left ventricular end-systolic pressure; LVEDP, left ventricular end-diastolic pressure; LVESV, left ventricular end-systolic volume; LVEDV, left ventricular end-diastolic volume; SV, stroke volume; CO, cardiac output; dP/dtmax, maximum time derivative of left ventricular pressure; EF, ejection fraction; Vcf, maximum velocity of circumferential fiber shortening. Ees, end-systolic elastance; V0, volume intercept of the end-systolic pressure-volume relation; Mw, slope of the preload recruitable stroke work relation; dE/dtma, VOLUME (ml) VOLUME (ml) VOLUME (ml) VOLUME (ml) 14 .6%, respectively, at the lower rate, and 14.5% versus 9%, respectively, at the higher rate). Consequently, the estimated ESPVR line generated by stepwise afterload decrease was significantly flatter than its control ESPVR, and that estimated from stepwise afterload increase was significantly steeper than its control ESPVR. Because the hemodynamic intervention (acute vena caval occlusion) used to construct the ESPVR varies the volume of the right ventricle, the role of direct ventricular interaction should be discussed. Slinker and Glantz48 demonstrated that in dogs with the pericardium removed (which is the case of our own dogs), direct ventricular interaction is about one fifth as important as series interaction at end diastole and only one sixth as important at end systole. Because the results of the present study refer to events taking place at end systole, it is unlikely that the misestimations of BesTRUE associated with the use of EeSEST could be attributed to the effect of direct ventricular interaction.
Clinical Implications
The results of this investigation indicate that the conclusions reached in clinical studies based on esti- mates of E,, obtained using stepwise steady-state afterload changes should be interpreted with care. When the effects of a drug or a pathophysiological situation or intervention expected to depress contractile state is assessed by the use of stepwise nitroprusside-induced afterload decreases, it must be taken into account that approximately 16% of any observed fall in Bes may be attributed to methodological error. If, on the other hand, the tested intervention is supposed to enhance contractility, the error associated with this method may offset the effect of the intervention and produce a false-negative result.
With the use of angiotensin-induced afterload increases, similar reasoning applies, but in this case 
